JNJ · NYSE · STOCK
Johnson & Johnson (JNJ) Stock Analysis
$261.50
52W $184.66 – $281.07
50/100
$630.04B
30.2
0.23
Is JNJ Bullish or Bearish?
Mixed.
Innellis AI committee rates Johnson & Johnson (JNJ) Watch with a composite score of 50/100
, based on 5 analysts with 60% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +9.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -10.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 25.7% shows genuine earnings power backing the valuation — Value
- Dividend yield of 3.1% pays you to wait — Value
Bear Case
- P/E of 29.8 is moderate-to-rich — Value
- Price-to-book of 6.1x prices in significant intangible value — Value
- EPS declining -7.8% YoY despite any revenue growth — Growth
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
50/100
Agreement
60%
Analysts
5
Conviction
Moderate
Sector Rank
Top 93%
of 192 Healthcare peers
Value Analyst
neutral
48
/ 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 25.7% shows genuine earnings power backing the valuation
− P/E of 29.8 is moderate-to-rich
Growth Analyst
bearish
32
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -7.8% YoY despite any revenue growth
Technical Analyst
neutral
48
/ 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 51.0 to 50.2.
- Conviction changed from contested to moderate.
- Committee agreement increased sharply from 40% to 60%.
- New bearish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
- Analyst(s) changed stance: News Analyst.
Analyst-level changes:
- News Analyst: stance bullish->neutral; score 62->58 (-4).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
49.8
Neutral
MACD Histogram
-1.059
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Mixed
Support
$220.42
Resistance
$281.00
Bollinger %B
0.37
Inside Bands
Price vs Moving Averages
EMA 9
$259.93
Above
EMA 21
$263.07
Below
EMA 50
$262.73
Below
EMA 200
$241.31
Above
Fundamental Analysis
Valuation
49
Growth
62
Profitability
100
Financial Health
60
Cash Flow
70
Valuation
P/E Ratio
30.2×
P/B Ratio
7.51×
PEG Ratio
-3.74
Dividend Yield
2.02%
52W High
$281.07
52W Low
$184.66
Quality & Growth
ROE
3287.1%
ROA
1345.5%
Gross Margin
6790.7%
Operating Margin
2681.1%
Revenue Growth YoY
—
Debt / Equity
0.58
AI Fundamental Assessment
P/E ratio of 30.2 (rich relative to a 15-40x range); Price-to-book of 7.5x; PEG ratio of -3.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 32.9%; Return on assets of 13.5%; Net margin of 21.5%; Gross margin of 67.9%; Current ratio of 1.09 (tight short-term liquidity); Debt-to-equity of 0.58; Free cash flow per share is positive (7.67); Most recent quarter beat estimates by 0.9%; 2 consecutive earnings beats; EPS growth decelerating (+9.8% -> +7.4% QoQ); Average YoY EPS growth of 4.7%; Analyst estimates rising over recent quarters
Get the Full JNJ Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →